Pretransplant Cognitive Function and Kidney Transplant Outcomes: A Prospective Cohort Study

IF 3.2 Q1 UROLOGY & NEPHROLOGY
Aditi Gupta , Michael J. Grasing , Kate J. Young , Robert N. Montgomery , Daniel J. Murillo , Diane M. Cibrik
{"title":"Pretransplant Cognitive Function and Kidney Transplant Outcomes: A Prospective Cohort Study","authors":"Aditi Gupta ,&nbsp;Michael J. Grasing ,&nbsp;Kate J. Young ,&nbsp;Robert N. Montgomery ,&nbsp;Daniel J. Murillo ,&nbsp;Diane M. Cibrik","doi":"10.1016/j.xkme.2024.100872","DOIUrl":null,"url":null,"abstract":"<div><h3>Background &amp; Hypothesis</h3><p>Cognitive impairment is common in patients being evaluated for a kidney transplant (KT). The association between pretransplant cognitive function and posttransplant outcomes is unclear.</p></div><div><h3>Study Design</h3><p>We performed a prospective cohort study to assess the association between pretransplant cognitive function and clinically relevant posttransplant outcomes.</p></div><div><h3>Setting and Population</h3><p>In this single center study, participants from the transplant clinic were evaluated during their pretransplant clinic visits and followed prospectively.</p></div><div><h3>Outcomes</h3><p>Our primary outcome measure was allograft function. Secondary outcomes were length of hospitalization for KT, hospital readmission within 30 and 90 days, graft loss, graft rejection within 90 days and 1 year, and mortality.</p></div><div><h3>Analytic Approach</h3><p>We measured cognitive function with the Montreal Cognitive Assessment (MoCA) test. We assessed the association of pretransplant MoCA score with posttransplant outcomes; we used linear mixed effects models to assess the association with the change in estimated glomerular filtration rate, Poisson regression for length of hospitalization, Cox proportional hazard model for graft loss and mortality, and a logistic regression model for readmission and rejection.</p></div><div><h3>Results</h3><p>We followed 501 participants for 2.7<!--> <!-->±<!--> <!-->1.5 years. The mean age of the patients was 53<!--> <!-->±<!--> <!-->14 years and the mean pretransplant MoCA score was 25<!--> <!-->±<!--> <!-->3. Lower pretransplant MoCA scores did not adversely affect the primary outcome of allograft function or the secondary outcomes. Although higher MoCA scores predicted a higher decline in graft function (β =<!--> <!-->−0.28, 95% CI: −0.55 to<!--> <!-->−0.01, <em>P</em> <!-->=<!--> <!-->0.04), the effect was small and not clinically significant. Older age was associated with longer hospitalization, lower likelihood of rejection, and higher mortality. Deceased donor KT (vs living donor KT) was associated with longer hospitalization but better graft function. Longer time receiving dialysis before KT was associated with longer hospitalization. A history of diabetes mellitus was associated with higher mortality.</p></div><div><h3>Limitations</h3><p>Single center study limiting generalizability.</p></div><div><h3>Conclusions</h3><p>Pretransplant MoCA scores were not associated with the primary outcome of allograft function or the secondary outcomes.</p></div><div><h3>Plain-Language Summary</h3><p>Cognitive impairment (problems with memory and thinking) is common in patients with kidney disease. Cognitive impairment is associated with problems following instructions and remembering to take medications. Medical adherence is important in kidney transplant recipients, and inability to follow instructions and missed doses of immunosuppression increases the risk of rejection of the transplanted kidney. However, kidney transplantation also improves cognition. Hence, transplant centers wonder if cognitive impairment before transplant affects clinical outcomes after kidney transplant. We tried to answer this question by assessing cognitive function before transplantation and examining whether pretransplant cognitive function affects graft function, length of hospitalization, readmission after transplantation, rejection, and death. We did not find any strong link between cognitive function before transplant and these outcomes.</p></div>","PeriodicalId":17885,"journal":{"name":"Kidney Medicine","volume":null,"pages":null},"PeriodicalIF":3.2000,"publicationDate":"2024-07-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2590059524000839/pdfft?md5=3b98778245197e9c2fd9b4c34cd4681f&pid=1-s2.0-S2590059524000839-main.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Kidney Medicine","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2590059524000839","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background & Hypothesis

Cognitive impairment is common in patients being evaluated for a kidney transplant (KT). The association between pretransplant cognitive function and posttransplant outcomes is unclear.

Study Design

We performed a prospective cohort study to assess the association between pretransplant cognitive function and clinically relevant posttransplant outcomes.

Setting and Population

In this single center study, participants from the transplant clinic were evaluated during their pretransplant clinic visits and followed prospectively.

Outcomes

Our primary outcome measure was allograft function. Secondary outcomes were length of hospitalization for KT, hospital readmission within 30 and 90 days, graft loss, graft rejection within 90 days and 1 year, and mortality.

Analytic Approach

We measured cognitive function with the Montreal Cognitive Assessment (MoCA) test. We assessed the association of pretransplant MoCA score with posttransplant outcomes; we used linear mixed effects models to assess the association with the change in estimated glomerular filtration rate, Poisson regression for length of hospitalization, Cox proportional hazard model for graft loss and mortality, and a logistic regression model for readmission and rejection.

Results

We followed 501 participants for 2.7 ± 1.5 years. The mean age of the patients was 53 ± 14 years and the mean pretransplant MoCA score was 25 ± 3. Lower pretransplant MoCA scores did not adversely affect the primary outcome of allograft function or the secondary outcomes. Although higher MoCA scores predicted a higher decline in graft function (β = −0.28, 95% CI: −0.55 to −0.01, P = 0.04), the effect was small and not clinically significant. Older age was associated with longer hospitalization, lower likelihood of rejection, and higher mortality. Deceased donor KT (vs living donor KT) was associated with longer hospitalization but better graft function. Longer time receiving dialysis before KT was associated with longer hospitalization. A history of diabetes mellitus was associated with higher mortality.

Limitations

Single center study limiting generalizability.

Conclusions

Pretransplant MoCA scores were not associated with the primary outcome of allograft function or the secondary outcomes.

Plain-Language Summary

Cognitive impairment (problems with memory and thinking) is common in patients with kidney disease. Cognitive impairment is associated with problems following instructions and remembering to take medications. Medical adherence is important in kidney transplant recipients, and inability to follow instructions and missed doses of immunosuppression increases the risk of rejection of the transplanted kidney. However, kidney transplantation also improves cognition. Hence, transplant centers wonder if cognitive impairment before transplant affects clinical outcomes after kidney transplant. We tried to answer this question by assessing cognitive function before transplantation and examining whether pretransplant cognitive function affects graft function, length of hospitalization, readmission after transplantation, rejection, and death. We did not find any strong link between cognitive function before transplant and these outcomes.

移植前认知功能与肾移植结果:前瞻性队列研究
背景与假设认知障碍在接受肾移植(KT)评估的患者中很常见。研究设计我们进行了一项前瞻性队列研究,以评估肾移植前认知功能与临床相关的肾移植后结果之间的关系。次要结果是 KT 住院时间、30 天和 90 天内再次入院、移植物丢失、90 天和 1 年内移植物排斥反应以及死亡率。我们评估了移植前 MoCA 评分与移植后结果的关系;我们使用线性混合效应模型评估了与估计肾小球滤过率变化的关系,使用泊松回归评估了住院时间,使用 Cox 比例危险模型评估了移植损失和死亡率,使用逻辑回归模型评估了再入院和排斥反应。患者的平均年龄为(53±14)岁,移植前的平均MoCA评分为(25±3)分。移植前较低的MoCA评分不会对异体移植功能的主要结果或次要结果产生不利影响。虽然较高的MoCA评分预示着较高的移植物功能下降率(β = -0.28,95% CI:-0.55 至 -0.01,P = 0.04),但影响较小,临床意义不大。年龄越大,住院时间越长,发生排斥反应的可能性越低,死亡率越高。死亡供体 KT(与活体供体 KT 相比)与住院时间较长但移植物功能较好有关。KT前接受透析的时间越长,住院时间越长。结论移植前MoCA评分与异体移植功能的主要结果或次要结果无关。认知障碍与遵从医嘱和记住服药有关。对于肾移植受者来说,遵守医嘱非常重要,不能遵守医嘱和漏服免疫抑制剂会增加移植肾发生排斥反应的风险。不过,肾移植也能改善认知能力。因此,移植中心想知道移植前的认知障碍是否会影响肾移植后的临床结果。我们试图通过评估移植前的认知功能来回答这个问题,并研究移植前的认知功能是否会影响移植功能、住院时间、移植后再入院、排斥反应和死亡。我们没有发现移植前认知功能与这些结果之间有任何密切联系。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Kidney Medicine
Kidney Medicine Medicine-Internal Medicine
CiteScore
4.80
自引率
5.10%
发文量
176
审稿时长
12 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信